A Coverage Policy Analysis on TMS is now available, providing clinicians and policy leaders with information on the comparative clinical effectiveness and value of TMS in treating patients with resistant-depression. This Coverage Policy Analysis includes the following components:
- Summary of CEPAC votes on TMS
- A supplementary report on TMS
- New England Medicare coverage policy for TMS
- Overview of CEPAC